{"id":"W2944338381","doi":"10.1158/1538-7445.sabcs18-p6-18-15","title":"Abstract P6-18-15: Ribociclib + endocrine therapy in hormone receptor-positive, HER2-negative advanced breast cancer: A pooled safety analysis","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Adverse effect; Letrozole; Fulvestrant; Anastrozole; Internal medicine; Common Terminology Criteria for Adverse Events; Breast cancer; Goserelin; Cancer; Placebo; Tamoxifen; Oncology; Gynecology; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009317345,0.0005505413,0.001356558,0.001189909,0.0002173519,0.00007015863,0.0005420357,0.0001999754,0.01341924],"category_scores_gemma":[0.00009952738,0.000486169,0.000372314,0.004785461,0.0005000037,0.0005742328,0.0001778575,0.001678839,0.0002227757],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002896655,"about_ca_system_score_gemma":0.0010607,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01257209,"about_ca_topic_score_gemma":0.002425021,"domain_scores_codex":[0.994316,0.0003667357,0.0007749698,0.001323368,0.001602457,0.001616444],"domain_scores_gemma":[0.9962996,0.0005853753,0.0002478258,0.001045894,0.001341057,0.0004803089],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.04023534,0.0007938255,0.1112053,0.0002131172,0.004138363,0.0001582768,0.002851621,0.002932361,0.4556781,0.00009299169,0.0007226132,0.3809781],"study_design_scores_gemma":[0.0149688,0.0006700472,0.9254397,0.0006804619,0.0001590508,0.00002656577,0.001489112,0.0001421047,0.0441278,0.0002109114,0.01143014,0.0006552645],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9761034,0.01081989,0.00004033359,0.006671712,0.0002170014,0.002528285,0.001121268,0.0001330045,0.002365061],"genre_scores_gemma":[0.9759604,0.01794764,0.0004137555,0.0004951758,0.0004096788,0.001100376,0.000150337,0.0001404701,0.003382187],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8142344,"threshold_uncertainty_score":0.999759,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03212609355398043,"score_gpt":0.3930988829096352,"score_spread":0.3609727893556548,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}